by jlohrconsulting | Sep 9, 2025 | Uncategorized
Metab Brain Dis. 2025 Sep 9;40(7):262. doi: 10.1007/s11011-025-01680-0. ABSTRACT This study aimed to evaluate the antidepressant potential of Nitazoxanide (NTZ), an antiprotozoal drug with known anti-inflammatory and neuroprotective properties, in a chronic...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
Acta Neurol Belg. 2025 Sep 9. doi: 10.1007/s13760-025-02890-0. Online ahead of print. ABSTRACT OBJECTIVES: Patients diagnosed with amyotrophic lateral sclerosis (ALS) typically describe symptoms of fatigue. Despite this frequency, the underlying mechanisms of fatigue...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
Community Ment Health J. 2025 Sep 9. doi: 10.1007/s10597-025-01489-2. Online ahead of print. ABSTRACT Guided by the Ottawa Decision Support Framework, we created a depression care decision aid for Latinx and African American individuals with major depressive disorder...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
JAMA Netw Open. 2025 Sep 2;8(9):e2529892. doi: 10.1001/jamanetworkopen.2025.29892. ABSTRACT IMPORTANCE: Patients with inflammatory rheumatic diseases (IRDs) frequently experience psychological distress; however, access to psychological support remains limited....
by jlohrconsulting | Sep 9, 2025 | Uncategorized
Proc Natl Acad Sci U S A. 2025 Sep 16;122(37):e2510642122. doi: 10.1073/pnas.2510642122. Epub 2025 Sep 9. ABSTRACT Major depressive disorder affects millions worldwide, yet current treatments require prolonged administration. In contrast, ketamine produces rapid...
by jlohrconsulting | Sep 9, 2025 | Uncategorized
J Med Internet Res. 2025 Sep 9;27:e68662. doi: 10.2196/68662. ABSTRACT BACKGROUND: The loss of a loved one is a common yet stressful event in later life. Internet- and mobile-based interventions have been proposed as an effective treatment approach for individuals...
Recent Comments